Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Medical Imaging and Pathology Studies, Sarcoidosis and Beryllium Toxicity Research, and Pulmonary Hypertension Research and Treatments.
Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer
Lung function trajectories in patients with idiopathic pulmonary fibrosis
Detection and Early Referral of Patients With Interstitial Lung Abnormalities
Hospitalizations in patients with idiopathic pulmonary fibrosis
Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire
Effect of nintedanib on biomarkers of extracellular matrix (ECM) turnover and FVC decline in patients with IPF: results from the INMARK study*
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis
Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis
Extracellular matrix in lung development, homeostasis and disease
Hypersensitivity Pneumonitis
αvβ3 Integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis
Optimising experimental research in respiratory diseases: an ERS statement
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis
Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
Joint SNMMI–ASNC Expert Consensus Document on the Role of <sup>18</sup>F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring
Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring
Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias
Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease
The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
In vitro generation of human pluripotent stem cell derived lung organoids
Blue Journal Conference. Aging and Susceptibility to Lung Disease
Inhibition of Myocardin-Related Transcription Factor/Serum Response Factor Signaling Decreases Lung Fibrosis and Promotes Mesenchymal Cell Apoptosis
Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell Function
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study